https://healthpr.bg/2021/04/19/curevacs-mrna-coronavirus-shot-boasts-one-advantage-over-pfizer-and-moderna-counterparts-refrigerated-storage/2026-03-06T21:46:02+02:00https://healthpr.bg/2021/02/22/30000-bulgarians-receive-jabs-against-covid-19-in-last-three-days/2026-03-06T21:46:03+02:00https://healthpr.bg/2019/09/25/bulgaria-resumes-the-green-corridor-walk-in-vaccination-scheme/2026-03-06T21:41:41+02:00https://healthpr.bg/2021/04/19/more-anti-epidemic-measures-eased-today-2/2026-03-06T21:46:02+02:00https://healthpr.bg/2020/08/17/covid-19-vaccine-players-will-split-100b-in-sales-and-40b-in-profits-with-moderna-leading-the-way-analyst/2026-03-06T21:42:18+02:00https://healthpr.bg/2021/08/10/more-anti-epidemic-measures-eased-today-3/2026-03-06T21:46:20+02:00https://healthpr.bg/2020/07/30/trump-big-pharma-trade-barbs-over-drug-pricing-eos-barda-gives-regeneron-350m-for-ebola-drugs/2026-03-06T21:42:18+02:00https://healthpr.bg/2020/07/30/after-big-pharma-abandoned-infectious-diseases-5-biotech-contrarians-decided-to-go-all-in-then-covid-19-changed-everything/2026-03-06T21:42:18+02:00https://healthpr.bg/2020/06/15/pharma-sales-rep-salary-survey-finds-annual-incomes-rising-but-covid-19-concerns-mounting/2026-03-06T21:42:18+02:00https://healthpr.bg/2020/06/19/bio-whats-the-roi-on-a-covid-19-vaccine-we-have-no-idea-says-pfizer/2026-03-06T21:42:18+02:00https://healthpr.bg/2020/05/04/coronavirus-tracker-t-cells-could-provide-hint-to-how-roches-actemra-treats-covid-19-patients/2026-03-06T21:42:02+02:00https://healthpr.bg/2020/05/02/blue-cross-mn-ceo-why-covid-19-may-be-making-the-case-for-value-based-care/2026-03-06T21:42:02+02:00https://healthpr.bg/2020/04/11/global-clinical-trials-take-a-major-hit-from-pandemic-with-endocrine-targeted-tests-worst-hit/2026-03-06T21:42:02+02:00https://healthpr.bg/2020/03/16/trump-tries-to-lure-curevac-to-make-a-u-s-vaccine-but-german-government-steps-in/2026-03-06T21:42:03+02:00https://healthpr.bg/2020/04/10/to-avoid-dtc-dips-and-communication-snafus-pharma-marketing-shifts-amid-covid-19-crisis/2026-03-06T21:42:02+02:00https://healthpr.bg/2020/03/14/biogen-cracks-down-on-travel-after-3-execs-test-positive-for-coronavirus/2026-03-06T21:42:03+02:00https://healthpr.bg/2020/03/04/why-fda-cant-disclose-the-first-coronavirus-related-drug-shortage/2026-03-06T21:42:03+02:00https://healthpr.bg/2020/02/28/the-top-10-ad-spenders-in-big-pharma-for-2019/2026-03-06T21:42:03+02:00https://healthpr.bg/2020/02/24/states-reject-drug-wholesalers-18b-opioid-settlement-offer-wsj/2026-03-06T21:41:40+02:00https://healthpr.bg/2019/06/26/concern-for-drug-shortages-grows-as-covid-19-outbreak-drags-on/2026-03-06T21:41:24+02:00https://healthpr.bg/2020/02/18/the-20-most-expensive-pharmacy-drugs-in-the-u-s-in-2020-from-fallen-blockbusters-to-new-orphan-meds/2026-03-06T21:41:40+02:00https://healthpr.bg/2021/02/28/bulgaria-resumes-the-green-corridor-walk-in-vaccination-scheme-2/2026-03-06T21:46:03+02:00https://healthpr.bg/2019/07/19/amgen-novartis-scrap-alzheimers-studies-is-bace-finally-dead-or-will-biogen-and-eisai-carry-on/2026-03-06T21:41:24+02:00https://healthpr.bg/2019/07/15/true-innovation-or-just-later-to-market-german-agency-questions-benefits-of-new-drugs/2026-03-06T21:41:24+02:00https://healthpr.bg/2019/06/20/silicon-valleys-most-anticipated-slide-deck-just-dropped-what-does-it-mean-for-biopharmas-digital-teams/2026-03-06T21:41:24+02:00https://healthpr.bg/2019/06/17/the-top-10-most-expensive-meds-in-the-u-s-and-theyre-not-the-usual-suspects/2026-03-06T21:41:24+02:00https://healthpr.bg/2019/05/07/if-pharma-looks-slow-to-adopt-ai-its-got-good-reason-expert-says/2026-03-06T21:41:25+02:00https://healthpr.bg/2019/04/29/big-pharma-cuts-current-and-coming/2026-03-06T21:41:25+02:00https://healthpr.bg/2019/04/25/how-biopharma-companies-use-nih-and-vice-versa/2026-03-06T21:41:25+02:00https://healthpr.bg/2019/04/22/in-another-crispr-first-penn-researchers-dose-us-cancer-patients-with-gene-edited-t-cell-therapy/2026-03-06T21:41:01+02:00https://healthpr.bg/2019/04/19/patients-are-not-a-companys-resource-fda-cancer-czar-richard-pazdur-has-a-bone-to-pick-with-the-top-rd-execs-in-cancer/2026-03-06T21:41:01+02:00https://healthpr.bg/2019/04/10/2020-what-does-the-future-hold-for-the-manufacturing-and-clinical-landscape/2026-03-06T21:41:01+02:00https://healthpr.bg/2019/04/07/a-key-step-for-the-future-of-personalized-medicine-crispr-immunity-and-mathematical-cryptanalysis/2026-03-06T21:41:01+02:00https://healthpr.bg/2019/04/05/pharmas-summer-of-punk-whos-playing-the-hits-or-taking-a-hit-on-the-world-innovation-tour/2026-03-06T21:41:02+02:00https://healthpr.bg/2019/04/02/a-new-regulation-in-force-may-block-the-patients-access-to-new-medicines/2026-03-06T21:41:02+02:00https://healthpr.bg/2019/03/20/a-new-regulation-in-force-may-block-the-patients-access-to-new-medicines-2/2026-03-06T21:41:02+02:00https://healthpr.bg/2019/03/19/a-new-regulation-in-force-may-block-the-patients-access-to-new-medicines-3/2026-03-06T21:41:02+02:00https://healthpr.bg/2019/03/07/after-november-rollout-gw-pharma-says-epidiolex-positioned-for-strong-growth/2026-03-06T21:41:02+02:00https://healthpr.bg/2019/03/07/fda-chief-scott-gottlieb-steps-down-leaving-pet-projects-behind/2026-03-06T21:41:02+02:00